| 000 | 01757 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516122039.0 | ||
| 264 | 0 | _c20130418 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1432-1335 | ||
| 024 | 7 |
_a10.1007/s00432-012-1327-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpitaleri, G | |
| 245 | 0 | 0 |
_aPhase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours. _h[electronic resource] |
| 260 |
_bJournal of cancer research and clinical oncology _cMar 2013 |
||
| 300 |
_a447-55 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCytokines _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xadministration & dosage |
| 700 | 1 | _aBerardi, R | |
| 700 | 1 | _aPierantoni, C | |
| 700 | 1 | _aDe Pas, T | |
| 700 | 1 | _aNoberasco, C | |
| 700 | 1 | _aLibbra, C | |
| 700 | 1 | _aGonzález-Iglesias, R | |
| 700 | 1 | _aGiovannoni, L | |
| 700 | 1 | _aTasciotti, A | |
| 700 | 1 | _aNeri, D | |
| 700 | 1 | _aMenssen, H D | |
| 700 | 1 | _ade Braud, F | |
| 773 | 0 |
_tJournal of cancer research and clinical oncology _gvol. 139 _gno. 3 _gp. 447-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00432-012-1327-7 _zAvailable from publisher's website |
| 999 |
_c22272593 _d22272593 |
||